Polymorphism

Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study

G. Y. Ji, Wang, Y., Wu, S. Q., Liu, Q. Q., Wu, J. C., Zhang, M. M., Sandford, A. J., He, J. Q., Ji, G. Y., Wang, Y., Wu, S. Q., Liu, Q. Q., Wu, J. C., Zhang, M. M., Sandford, A. J., and He, J. Q., Association between TXNRD1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in a prospective study, vol. 15, p. -, 2016.

Anti-tuberculosis drug-induced hepatotoxicity (ATDH) is a serious adverse reaction to anti-tuberculosis (TB) treatment. Thioredoxin reductase 1 (TXNRD1), encoded by the TXNRD1 gene, is an important enzyme involved in oxidant challenge. TXNRD1 plays a key role in regulating cell growth and transformation, and protects cells against oxidative damage. We investigated the association between TXNRD1 polymorphisms and ATDH susceptibility. In this prospective study, 280 newly diagnosed TB patients were followed-up for 3 months after beginning anti-TB therapy.

Subscribe to Polymorphism